Bronchospasm and dyspnoea associated with chronic obstructive pulmonary disease
Treatment Phase: Long-term maintenance treatment
Bronchospasm and dyspnoea associated with chronic obstructive pulmonary disease
Treatment Phase: Long-term maintenance treatment
The treatment must not be used in combination with a LAMA/LABA or SAMA
A LAMA/LABA includes aclidinium/formoterol, glycopyrronium/indacaterol, tiotropium/olodaterol, or umeclidinium/vilanterol.
A SAMA includes ipratropium
Diagnosis of COPD should include measurement of airflow obstruction using spirometry, with confirmation of post-bronchodilator airflow obstruction.
Adherence to current treatment and device (inhaler) technique should be reviewed at each clinical visit and before "stepping up" a patient's medication regimen.